1 – 5 of 13
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa Infusion
2024) In Movement Disorders Clinical Practice(
- Contribution to journal › Article
- 2022
-
Mark
Testosterone associates differently with body mass index and age in serum and cerebrospinal fluid in men
(
- Contribution to journal › Letter
-
Mark
Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease
(
- Contribution to journal › Article
- 2020
-
Mark
Neuroimaging, genetic, clinical, and demographic predictors of treatment response in patients with social anxiety disorder
(
- Contribution to journal › Article
- 2010
-
Mark
Associations between the angiotensin-converting enzyme insertion/deletion polymorphism and monoamine metabolite concentrations in cerebrospinal fluid
(
- Contribution to journal › Article